Laboratorios Farmaceuticos ROVI (ROVI)

Real-time derived


Symbol	Exchange	Currency
ROVI	Madrid	EUR	Delayed
ROVI	Derived	EUR	Real-time
ROVI	Vienna	EUR	Real-time

Currency in EUR

Disclaimer

80.800

+1.850(+2.34%)

Closed07/09

Fair Value

Unlock Value

Day's Range

79.150

81.150

52 wk Range

46.780

94.800

ROVI Cash Flow Statement
Featured here, the Cash Flow Statement for Laboratorios Farmaceuticos ROVI, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Advanced Cash Flow Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Cash from Operations

aa.aa

-9.04

46.88

149.44

237.6

113.25

	Cash from Operations Growth
	Net Income
	Depreciation & Amortisation, Total
	Amortisation of Deferred Charges, Total
	Other Non-Cash Items, Total
	Change in Net Operating Assets

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-206.01%	+618.31%	+218.8%	+58.99%	-52.34%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	39.27	61.06	153.08	199.67	170.34
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	17	18.31	20.3	22.87	24.33
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.21	1.29	1.06	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.87	29.98	39.03	72.04	-46.97
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-63.67	-63.75	-64.03	-56.97	-34.45

Cash from Investing

aa.aa

-40.47

-39.63

-40.84

-57.15

-52.03

	Cash from Investing Growth
	Capital Expenditure
	Sale of Property, Plant, and Equipment
	Cash Acquisitions
	Divestitures
	Other Investing Activities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-54.23%	+2.09%	-3.06%	-39.95%	+8.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-25.9	-39.34	-40.22	-50.72	-53.79
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0	0.06	0.03	0.08	0.38
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-14.58	-0.35	-0.65	-6.51	1.38

Cash from Financing

aa.aa

21.43

-21.52

-62.73

-154.54

-160.84

	Cash from Financing Growth
	Total Debt Issued
	Short Term Debt Issued, Total
	Long-Term Debt Issued, Total
	Total Debt Repaid
	Short Term Debt Repaid, Total
	Long-Term Debt Repaid, Total
	Issuance of Common Stock
	Repurchase of Common Stock
	Issuance of Preferred Stock
	Repurchase of Preferred Stock
	Common & Preferred Stock Dividends Paid
	Special Dividend Paid
	Other Financing Activities
	Foreign Exchange Rate Adjustments
	Miscellaneous Cash Flow Adjustments

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-70.45%	-200.39%	-191.56%	-146.36%	-4.08%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	47.03	1.43	1.34	1.4	0.73
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	47.03	1.43	1.34	1.4	0.73
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-21.24	-13.18	-6.19	-6.77	-13.65
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-21.24	-13.18	-6.19	-6.77	-13.65
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.87	37.49	42.33	77.77	52.64
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-4.72	-37.26	-78.79	-177.01	-133.9
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-4.42	-9.7	-21.13	-51.01	-69.05
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.09	-0.3	-0.29	1.08	2.39
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Net Change in Cash

aa.aa

-28.09

-14.26

45.87

25.91

-99.62

	Beginning Cash Balance
	Ending Cash Balance
	Levered Free Cash Flow
	Levered Free Cash Flow Growth
	Free Cash Flow Yield

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	95.51	67.43	53.16	99.04	124.95
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	67.43	53.16	99.04	124.95	25.32
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-64.27	-12.05	66.2	135.83	25.34
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-178.39%	+81.25%	+649.31%	+105.19%	-81.35%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-3.68	0.34	2.65	9.57	1.78

* In Millions of EUR (except for per share items)

S&P/ASX 200

8,013.40

+31.00

+0.39%

ASX 200 Futures

7,872.00

-88.5

-1.11%

ASX All Ordinaries

8,214.80

+27.10

+0.33%

US 500

5,395.20

-108.2

-1.97%

Dow Jones

40,345.41

-410.34

-1.01%

China A50 Futures

11,382.00

-96.5

-0.84%

Dollar Index

101.14

+0.070

+0.07%

Market Movers

Name	Last	Chg. %	Vol.
BHP Group Ltd	38.450	-1.18%	8.38M
Woodside Energy	24.020	-3.92%	8.14M
ANZ Holdings	31.790	+1.73%	6.76M
Westpac Banking	32.100	+1.65%	5.77M
National Australia Bank	39.050	+1.43%	4.17M
Commonwealth Bank Australia	143.470	+1.50%	2.81M
Macquarie	225.170	+2.37%	984.38K

Name	Last	Chg. %	Vol.
Osmond Resources	0.17	+142.86%	4.61M
North Stawell	0.02	+100.00%	405.24K
Desert Metals	0.03	+50.00%	386.29K
Audeara	0.04	+33.33%	27.30K
Blackstone Minerals	0.049	+24.39%	276.89K
ECHOIQ LIMITED	0.185	+18.75%	5.91M
Ark Mines Ltd	0.195	+18.18%	32.97K

Name	Last	Chg. %	Vol.
Bryah Resources	0.01	-100.00%	50.00K
HitiQ	0.02	-50.00%	47.62K
Miramar	0.01	-50.00%	30.77M
Mamba Exploration	0.01	-50.00%	12.03K
CareTeQ LLC	0.01	-50.00%	38.47K
Nickelsearch	0.02	-50.00%	606.27K
Chimeric Therapeutics	0.02	-50.00%	505.87K

Trending Stocks

Name	Last	Chg. %	Vol.
Woodside Energy	24.020	-3.92%	8.14M
Fortescue Metals	16.120	-0.06%	8.83M
Commonwealth Bank Australia	143.470	+1.50%	2.81M
Westpac Banking	32.100	+1.65%	5.77M
BHP Group Ltd	38.450	-1.18%	8.38M

Popular Searches

Please try another search

Laboratorios Farmaceuticos ROVI (ROVI)

ROVI Cash Flow Statement
Featured here, the Cash Flow Statement for Laboratorios Farmaceuticos ROVI, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

Please try another search

Laboratorios Farmaceuticos ROVI (ROVI)

ROVI Cash Flow StatementFeatured here, the Cash Flow Statement for Laboratorios Farmaceuticos ROVI, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

ROVI Cash Flow Statement
Featured here, the Cash Flow Statement for Laboratorios Farmaceuticos ROVI, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).